J Corral1,2, J Solà1,2, J Galceran3,4, R Marcos-Gragera5,6,7,8, M Carulla3,4, Á Izquierdo5,6,9, L Vilardell5,6, L Llauradó3, J A Espinàs1,2, J M Borras10,11,12. 1. Cancer Plan, Department of Health, Generalitat de Catalunya, Barcelona, Spain. 2. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. 3. Tarragona Cancer Registry, Foundation League for Research Into the Prevention of Cancer (FUNCA), Reus, Spain. 4. Pere Virgili Health Research Institute (IISPV), Reus, Spain. 5. Epidemiology Unit and Girona Cancer Registry, Cancer Plan, Department of Health, Generalitat de Catalunya, Catalan Institute of Oncology, Girona, Spain. 6. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. 7. University of Girona (UdG), Girona, Spain. 8. Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. 9. Medical Oncology Department, Hospital Josep Trueta, Catalan Institute of Oncology of Girona, Girona, Spain. 10. Cancer Plan, Department of Health, Generalitat de Catalunya, Barcelona, Spain. jmborras@iconcologia.net. 11. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. jmborras@iconcologia.net. 12. Department of Clinical Sciences, University of Barcelona, Barcelona, Spain. jmborras@iconcologia.net.
Abstract
PURPOSE: To assess the use of external beam radiotherapy in Catalonia (Spain), overall and by health management area. METHODS: We assessed radiotherapy treatments in a cohort of patients diagnosed with cancer from 2009 to 2011, using the population-based cancer registries in Girona and Tarragona. Participants had to have a minimum follow-up of 5 years from the time the cancer registry database was linked to the catalan health service database for financing radiation oncology. Outcomes included the proportion of patients receiving radiotherapy within 1 and 5 years of diagnosis. A log-binomial model was used to assess age-related trends in the use of radiotherapy by tumour site. Finally, we calculated the standardized utilization rate and 95% confidence intervals by health management area covered by the radiation oncology services, using indirect methods. RESULTS: At 1 and 5 years from diagnosis, 21.4 and 24.4% of patients, respectively, had received external beam radiotherapy. Patients aged 40-64 years had the most indications for the treatment, and there was a negative correlation between the patients' age and the use of radiotherapy for most tumour sites (exceptions were cervical, thyroid, and uterine cancers). There were no statistically significant differences in the use of radiotherapy according to th health management area. CONCLUSIONS: Population-based data show that external beam radiotherapy is underutilized in Catalonia. This situation requires a careful analysis to understand the causes, as well as an improvement of the available resources, oriented toward achieving realistic targets for the optimal use of external beam radiotherapy in our country.
PURPOSE: To assess the use of external beam radiotherapy in Catalonia (Spain), overall and by health management area. METHODS: We assessed radiotherapy treatments in a cohort of patients diagnosed with cancer from 2009 to 2011, using the population-based cancer registries in Girona and Tarragona. Participants had to have a minimum follow-up of 5 years from the time the cancer registry database was linked to the catalan health service database for financing radiation oncology. Outcomes included the proportion of patients receiving radiotherapy within 1 and 5 years of diagnosis. A log-binomial model was used to assess age-related trends in the use of radiotherapy by tumour site. Finally, we calculated the standardized utilization rate and 95% confidence intervals by health management area covered by the radiation oncology services, using indirect methods. RESULTS: At 1 and 5 years from diagnosis, 21.4 and 24.4% of patients, respectively, had received external beam radiotherapy. Patients aged 40-64 years had the most indications for the treatment, and there was a negative correlation between the patients' age and the use of radiotherapy for most tumour sites (exceptions were cervical, thyroid, and uterine cancers). There were no statistically significant differences in the use of radiotherapy according to th health management area. CONCLUSIONS: Population-based data show that external beam radiotherapy is underutilized in Catalonia. This situation requires a careful analysis to understand the causes, as well as an improvement of the available resources, oriented toward achieving realistic targets for the optimal use of external beam radiotherapy in our country.
Entities:
Keywords:
Access; Cancer incidence; Cancer registry; External beam radiotherapy; Utilization
Authors: Francisco Carrasco-Peña; Eloisa Bayo-Lozano; Miguel Rodríguez-Barranco; Dafina Petrova; Rafael Marcos-Gragera; Maria Carmen Carmona-Garcia; Josep Maria Borras; Maria-José Sánchez Journal: Int J Environ Res Public Health Date: 2020-09-14 Impact factor: 3.390